Article
<i>CTNS</i> mRNA as a potential treatment for nephropathic cystinosis
2023-04-29
Abstract excerpt
Messenger RNA (mRNA) therapies are emerging in different disease areas, but have not yet reached the kidney field. Our aim was to study the feasibility to correct the genetic defect in nephropathic cystinosis using synthetic mRNA. Cystinosis is a prototype disorder of proximal tubular dysfunction caused by mutations in the CTNS gene, encoding the lysosomal cystine-H + symporter cystinosin, and leading to cystine...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 61a6ebe7-e943-5952-a328-38bfd907ac3b
- DOI
- 10.1101/2023.04.28.538106
